Medtronic ROE 2006-2018 | MDT

Current and historical return on equity (ROE) values for Medtronic (MDT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Medtronic ROE for the three months ending October 31, 2018 was 13.51%.
Medtronic ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-10-31 $2.26B $49.71B 4.49%
2018-07-31 $3.16B $50.33B 6.23%
2018-04-30 $3.10B $50.82B 6.10%
2018-01-31 $2.81B $50.34B 5.53%
2017-10-31 $5.02B $51.58B 9.93%
2017-07-31 $4.12B $50.79B 8.19%
2017-04-30 $4.03B $50.33B 8.02%
2017-01-31 $3.97B $49.49B 7.83%
2016-10-31 $4.24B $50.29B 8.32%
2016-07-31 $3.65B $50.89B 7.08%
2016-04-30 $3.54B $52.06B 6.81%
2016-01-31 $2.43B $50.82B 4.66%
2015-10-31 $2.32B $52.27B 5.19%
2015-07-31 $2.62B $52.81B 7.21%
2015-04-30 $2.68B $53.23B 9.55%
2015-01-31 $3.12B $20.17B 15.96%
2014-10-31 $2.91B $19.44B 15.02%
2014-07-31 $2.98B $19.25B 15.54%
2014-04-30 $3.07B $19.44B 16.12%
2014-01-31 $3.59B $19.35B 19.05%
2013-10-31 $3.81B $18.74B 20.67%
2013-07-31 $3.56B $18.52B 19.70%
2013-04-30 $3.47B $18.67B 19.55%
2013-01-31 $3.49B $17.84B 20.11%
2012-10-31 $3.44B $17.18B 20.00%
2012-07-31 $3.66B $17.26B 21.44%
2012-04-30 $3.62B $17.11B 21.48%
2012-01-31 $3.40B $17.17B 20.56%
2011-10-31 $3.39B $16.74B 21.07%
2011-07-31 $3.09B $16.34B 19.76%
2011-04-30 $3.10B $15.97B 20.38%
2011-01-31 $3.28B $15.36B 22.05%
2010-10-31 $3.18B $14.83B 21.80%
2010-07-31 $3.48B $14.60B 24.38%
2010-04-30 $3.10B $14.63B 22.25%
2010-01-31 $2.25B $14.32B 16.56%
2009-10-31 $2.11B $13.61B 15.95%
2009-07-31 $1.79B $13.14B 13.78%
2009-04-30 $2.07B $13.18B 16.20%
2009-01-31 $2.69B $13.06B 21.74%
2008-10-31 $2.07B $12.62B 17.46%
2008-07-31 $2.19B $12.24B 18.92%
2008-04-30 $2.14B $11.54B 18.95%
2008-01-31 $2.23B $10.97B 20.02%
2007-10-31 $2.86B $11.48B 25.69%
2007-07-31 $2.88B $11.14B 26.54%
2007-04-30 $2.80B $10.98B 26.60%
2007-01-31 $2.73B $10.98B 26.93%
2006-10-31 $2.69B $10.28B 26.05%
2006-07-31 $2.83B $9.90B 26.81%
2006-04-30 $2.55B $9.38B 23.78%
2006-01-31 $2.00B $11.74B 18.25%
2005-10-31 $1.88B $11.13B 17.71%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $128.234B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $124.559B 25.24
Stryker (SYK) United States $64.068B 24.15
Boston Scientific (BSX) United States $50.024B 25.28
Baxter (BAX) United States $34.845B 22.50
Zimmer Biomet Holdings (ZBH) United States $22.662B 14.70
Smith & Nephew SNATS (SNN) United Kingdom $16.335B 0.00
ResMed (RMD) United States $16.088B 30.68
Perrigo (PRGO) Ireland $7.994B 12.13
Bio-Rad Laboratories (BIO) United States $7.541B 48.22
Canopy Growth (CGC) Canada $7.202B 0.00
Hill-Rom Holdings (HRC) United States $6.313B 19.75
Aurora Cannabis (ACB) Canada $5.710B 30.16
Haemonetics (HAE) United States $5.386B 47.36
Insulet (PODD) United States $4.873B 0.00
ICU Medical (ICUI) United States $4.823B 26.87
Hutchison China MediTech (HCM) China $4.087B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.703B 0.00
Neogen (NEOG) United States $3.227B 48.87
Agios Pharmaceuticals (AGIO) United States $3.067B 0.00
NuVasive (NUVA) United States $2.881B 26.81
National Vision Holdings (EYE) United States $2.462B 47.61
NxStage Medical (NXTM) United States $1.923B 0.00
Quidel (QDEL) United States $1.887B 24.60
Aphria (APHA) $1.401B 0.00
Phibro Animal Health (PAHC) United States $1.335B 18.89
AtriCure (ATRC) United States $1.205B 0.00
Cardiovascular Systems (CSII) United States $1.013B 1457.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.827B 21.44
Meridian Bioscience (VIVO) United States $0.780B 24.85
Surmodics (SRDX) United States $0.773B 117.67
OraSure Technologies (OSUR) United States $0.754B 42.45
Cerus (CERS) United States $0.748B 0.00
Omeros (OMER) United States $0.679B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.663B 21.26
Lantheus Holdings (LNTH) United States $0.647B 20.02
MacroGenics (MGNX) United States $0.568B 0.00
NanoString Technologies (NSTG) United States $0.537B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.03
Owens & Minor (OMI) United States $0.454B 5.13
Quanterix (QTRX) United States $0.443B 0.00
TG Therapeutics (TGTX) United States $0.424B 0.00
Insys Therapeutics (INSY) United States $0.382B 0.00
Evolus (EOLS) United States $0.374B 0.00
Utah Medical Products (UTMD) United States $0.340B 21.97
VAPOTHERM INC (VAPO) United States $0.318B 0.00
Cytosorbents (CTSO) United States $0.287B 0.00
Bovie Medical (BVX) United States $0.240B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.234B 0.00
Surface Oncology (SURF) United States $0.231B 0.00
BioLife Solutions (BLFS) United States $0.208B 281.75
Chimerix (CMRX) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.171B 0.00
Fonar (FONR) United States $0.134B 6.71
Imprimis Pharmaceuticals (IMMY) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.66
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.071B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.039B 0.00
Myomo (MYO) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00